For this reason, and due to the unknown health effects and safety of testosterone therapy, its use may be inappropriate. A subsequent 2017 systematic review and meta-analysis of studies including over 3,000 postmenopausal women with HSDD similarly found that short-term transdermal testosterone therapy was effective in improving multiple domains of sexual function. To take advantage of its virilizing effects, testosterone, often shortened to T, is administered to transgender men and other transmasculine individuals as part of masculinizing hormone therapy, titrated to clinical effect with a "target level" of the average male's testosterone level. Geriatric patients treated with androgens may also be at risk for worsening of signs and symptoms of BPH see WARNINGS AND PRECAUTION. There are insufficient long-term safety data in geriatric patients to assess the potential for increased risks of cardiovascular disease and prostate cancer. The Natesto Savings Program offer is valid only for eligible patients 18 years of age or over. Eligible, commercially insured patients may pay as little as $0 co-pay on each valid Natesto prescription or refill, up to an annual maximum of $3500. (b) Visual representation of the suppression of endogenous testosterone production for (i) a patient with more severe TDS, and (ii) a patient with less severe TDS. A C17β ether prodrug of testosterone, cloxotestosterone acetate, has also been marketed, although it is little known and is used very rarely or no longer. Major testosterone esters include testosterone cypionate, testosterone enanthate, testosterone propionate, and testosterone undecanoate. These include oral, buccal, sublingual, intranasal, transdermal (gels, creams, patches), rectal suppositories), by intramuscular or subcutaneous injection (in oil or aqueous), and as a subcutaneous implant. The ARs are expressed widely throughout the body, including in the penis, testicles, epididymides, prostate gland, seminal vesicles, fat, skin, bone, bone marrow, muscle, larynx, heart, liver, kidneys, pituitary gland, hypothalamus, and elsewhere throughout the brain. In addition to DHT, testosterone is converted at a rate of approximately 0.3% into the estrogen estradiol via aromatase. Surprisingly, patients report higher convenience with TNG than with once-daily topical gels . TNG 4.5% testosterone nasal gel (Natesto®; Acerus Pharmaceuticals Corporation, Mississauga, Ontario, Canada) is a thixotropic gel that is applied in the nasal cavity . Patients and physicians weigh advantages and disadvantages of each option to select a treatment that best fits the therapeutic needs, preferences, safety, tolerances, and lifestyle of the patient. Patients with severe testosterone deficiency had similar efficacy improvements as the remainder of the study population.
